Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KATHERINE M MORETZ

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1619191103
CMS profile
254866
Location
SAVANNAH, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$22,175.40

144 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 3; records 51–100 of 144 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KATHERINE M MORETZ

NPI 1619191103 · CMS profile ID 254866

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology with Special Qualifications in Child Neurology

SAVANNAH, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 144 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619191103?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KATHERINE M MORETZ, NPI 1619191103, CMS profile ID 254866. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 144 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619191103?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). KATHERINE M MORETZ, NPI 1619191103, CMS profile ID 254866. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 144 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619191103?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
KATHERINE M MORETZ, NPI 1619191103, CMS profile ID 254866, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 144 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1619191103?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

144 matching records · $22,175.40 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 144 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 144.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
CSL Behring $19.5708/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820283009 CMS
HARMONY BIOSCIENCES LLC $12.8708/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853078339 CMS
Greenwich Biosciences, Inc. $25.0008/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842253 CMS
Greenwich Biosciences, Inc. $194.7708/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842257 CMS
Greenwich Biosciences, Inc. $339.2808/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842261 CMS
Greenwich Biosciences, Inc. $41.6708/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842263 CMS
Greenwich Biosciences, Inc. $2,534.0008/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842267 CMS
Merz Pharmaceuticals, LLC $12.5208/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845433719 CMS
Biogen, Inc. $14.5808/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827774541 CMS
UCB, Inc. $15.9408/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807407105 CMS
Kyowa Kirin, Inc. $12.8608/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852989497 CMS
SK Life Science, Inc. $15.4808/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826819375 CMS
Celgene Corporation $16.4708/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783696063 CMS
Neurelis, Inc. $10.7308/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842873835 CMS
Greenwich Biosciences, Inc. $2,896.0008/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842235 CMS
Greenwich Biosciences, Inc. $112.7008/17/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842239 CMS
Greenwich Biosciences, Inc. $26.1908/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842243 CMS
Greenwich Biosciences, Inc. $155.6808/17/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842245 CMS
Greenwich Biosciences, Inc. $453.3908/17/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842249 CMS
Novartis Pharmaceuticals Corporation $11.6008/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813095631 CMS
Medtronic, Inc. $12.0708/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827397143 CMS
Greenwich Biosciences, Inc. $17.0508/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842177 CMS
Sunovion Pharmaceuticals Inc. $20.1608/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821652347 CMS
Alexion Pharmaceuticals, Inc. $19.3407/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114463 CMS
Biogen, Inc. $17.5707/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827774525 CMS
Neurelis, Inc. $6.9307/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842873831 CMS
Greenwich Biosciences, Inc. $16.4807/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842169 CMS
Mallinckrodt Hospital Products Inc. $19.6207/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845370615 CMS
UCB, Inc. $18.8307/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807368687 CMS
Biogen, Inc. $14.4507/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827774551 CMS
Greenwich Biosciences, Inc. $12.9506/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842161 CMS
Greenwich Biosciences, Inc. $1,448.0006/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842231 CMS
Novartis Pharmaceuticals Corporation $12.2006/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813095627 CMS
Greenwich Biosciences, Inc. $19.0106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842149 CMS
Neurelis, Inc. $14.7206/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842873827 CMS
Greenwich Biosciences, Inc. $90.4306/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842157 CMS
Biogen, Inc. $12.7206/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827774539 CMS
UCB, Inc. $14.9106/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807360897 CMS
Sunovion Pharmaceuticals Inc. $17.9106/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821724303 CMS
SANOFI-AVENTIS U.S. LLC $16.9206/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843592453 CMS
Biogen, Inc. $15.1306/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827774527 CMS
SK Life Science, Inc. $15.4806/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826819341 CMS
Greenwich Biosciences, Inc. $181.0006/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842227 CMS
Neurelis, Inc. $7.4905/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842873823 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $13.3405/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844024767 CMS
Biogen, Inc. $12.7205/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827774537 CMS
Alnylam Pharmaceuticals Inc. $14.0205/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828514181 CMS
Mallinckrodt Hospital Products Inc. $17.5905/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845370613 CMS
JAZZ PHARMACEUTICALS INC. $15.7605/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845588445 CMS
Greenwich Biosciences, Inc. $15.2305/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841842117 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $39,904.86 209
PY2020 $12,904.19 140
PY2021 $22,175.40 144
PY2022 $29,405.53 167
PY2023 $25,844.16 170
PY2024 $5,989.89 121
PY2025 $8,109.48 124

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $16,032.41 12
PY2024 Recipient $2,314.00 1
PY2024 Principal investigator $174,930.46 58
PY2023 Recipient $8,139.90 6
PY2023 Principal investigator $213,685.74 61
PY2022 Recipient $297.00 1
PY2022 Principal investigator $276,398.91 94
PY2021 Recipient $5,201.24 3
PY2021 Principal investigator $245,802.13 86
PY2020 Recipient $868.08 2
PY2020 Principal investigator $103,489.95 33
PY2019 Principal investigator $148,111.17 40

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,915.00 10/07/2025 Non-covered Recipient Entity
WCG Clinical, Inc. WCG IRB, LLC
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures No dispute reported 06/30/2026 1233746312
Principal investigator 1 Eisai Inc. $1,079.00 08/27/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy No dispute reported 06/30/2026 1244559934
Principal investigator 1 Eisai Inc. $139.00 08/27/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy No dispute reported 06/30/2026 1244559936
Principal investigator 1 Eisai Inc. $6,443.76 08/27/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy No dispute reported 06/30/2026 1244559938
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $1,575.50 04/28/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age No dispute reported 06/30/2026 1244050224
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $1,406.00 03/25/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
A Multicenter, Open-Label Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Pediatric Patients 6 to 17 Years of Age No dispute reported 06/30/2026 1244050232
Principal investigator 1 Eli Lilly and Company $100.00 01/31/2025 Non-covered Recipient Entity
NEW HORIZON RESEARCH CENTER
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN PATIENTS 6 TO 17 YEARS OF AGE WITH EPISODIC MIGRAINE - THE REBUILD STUDY No dispute reported 06/30/2026 1187884670
Principal investigator 1 PFIZER INC. $1,393.65 01/23/2025 Non-covered Recipient Entity
Meridian Clinical Research LLC
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RIMEGEPANT IN MIGRAINE PREVENTION IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE No dispute reported 06/30/2026 1228766388
Principal investigator 1 Eli Lilly and Company $958.00 01/21/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH INC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN PATIENTS 6 TO 17 YEARS OF AGE WITH EPISODIC MIGRAINE - THE REBUILD STUDY No dispute reported 06/30/2026 1187892374
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $7.50 01/03/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age No dispute reported 06/30/2026 1244050220
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $7.50 01/02/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age No dispute reported 06/30/2026 1244050218
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $7.50 01/01/2025 Non-covered Recipient Entity
MERIDIAN CLINICAL RESEARCH LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age No dispute reported 06/30/2026 1244050216